Approximately half of all adults (Garfield [@CR68]; Wierzbicki and Pekarik [@CR65]) drop out of outpatient therapy; the range is wider for youths, with estimates that approximately 35--75% of children terminate services before the provider would agree that it is appropriate (Kazdin [@CR27]; Miller et al. [@CR42]). These findings suggest that many ostensibly "treated" individuals in need of mental health services receive less than an adequate dose of care. Attrition results in inefficient use of services in the present (Armbruster and Kazdin [@CR3]) and may create additional costs in the future as individuals with unresolved symptoms return to care in a quick churning of short, under-dosed episodes (Kazdin [@CR27]).

The majority of research on attrition has focused on adult populations, and findings have spurred the development of brief engagement interventions designed to address practical and psychological barriers to treatment participation (see Walitzer et al. [@CR57]). Initial studies of engagement in child mental health services and the use of adjunct services for attrition prevention have shown promise (May et al. [@CR38]; McKay et al. [@CR41]; Nock and Kazdin [@CR44]); however, work on engagement and reducing attrition from youth mental health services remains scarce and identification of risk factors for attrition is an important prerequisite to such interventions. The relatively small body of work on attrition from youth psychotherapy has yielded inconsistent findings and has been dominated by studies of children and adolescents with disruptive behavior disorders (e.g., Armbruster and Kazdin [@CR3]; Friars and Mellor [@CR19]; Gross et al. [@CR22]; Kazdin et al. [@CR31]; Kazdin and Mazurick [@CR29]; Kazdin and Wassell [@CR30]; Luk et al. [@CR36]) or general clinical samples (Attride-Stirling et al. [@CR4]; Miller et al. [@CR42]; Pelkonen et al. [@CR46]). This is not surprising, as parents more often refer their children for treatment of externalizing than internalizing problems (Sayal et al. [@CR48]; Wu et al. [@CR67]). In the community, however, there is evidence that, as a class, anxiety is one of the most common youth mental health disorders (Cartwright-Hatton et al. [@CR11]; Costello et al. [@CR14]; Kashani and Orvaschel [@CR26]). Untreated, early-onset anxiety often continues into adulthood (Dadds et al. [@CR15]; Keller et al. [@CR32]), and predicts academic underachievement, substance dependence (Woodward and Fergusson [@CR66]), and the development of depression and conduct disorder (Bittner et al. [@CR10]).

Given the persistent course of anxiety, retention of these youths in treatment for an adequate dose of care seems an important public health priority, and research is needed to identify reliable risk factors of treatment non-completion in youths with clinically significant anxiety. Youths with anxiety are most often served in school or community-based outpatient mental health settings (Chavira et al. [@CR12]), yet most of what is known regarding attrition among anxious youths is born from samples receiving treatment within the context of specialty clinics or randomized control trials (RCTs). To date, two studies have examined attrition among clinically anxious youths. Both found that a substantial portion of youths do not complete treatment (23%), however, characteristics of completers and noncompleters were not consistent across these investigations. One study found that among anxious youth receiving cognitive-behavioral therapy (CBT) in a university specialty outpatient clinic, treatment dropouts were more likely to live in a single parent household, be an ethnic minority, and report lower anxiety at baseline than youths who completed treatment (Kendall and Sugarman [@CR33]). By contrast, a subsequent study in a different research clinic produced no statistically significant differences between completers and noncompleters of CBT for phobias and anxiety across a combined dataset from two trials (Pina et al. [@CR47]).

Given the availability of efficacious treatments for youth anxiety (see Compton et al. [@CR13]; Silverman et al. [@CR50]), successful delivery of these services in non-research clinical practice appears an important next step (Emslie [@CR17]; La Greca et al. [@CR34]). As an intermediate step toward treatment dissemination, it seems critical to understand the current status of care for anxious youths, including length of stay and predictors of attrition and to understand these factors within the context of anxious youths as they present in community settings. While previous attrition findings provide a useful springboard for selecting a priori predictors of attrition among anxious youths, it is reasonable to question whether findings from these samples are directly applicable to youths served in public sectors of care due to significant differences between the samples of youths and types of treatments received in usual care versus clinical research.

While RCTs strive to include demographically and clinically diverse youths with some success, there remain substantial differences between RCT samples and youths who attend outpatient mental health centers (OMHCs). In OMHCs, anxious youth often have more severe psychiatric comorbidity, are more likely a member of an ethnic minority group, and may more likely come from low-income, single parent families (Southam-Gerow et al. [@CR53]). As discussed previously, these demographic factors have been associated with attrition within one university clinic data set (Kendall and Sugarman [@CR33]) and the increased prevalence of these risk factors bodes poorly for retention of anxious youth in OMHC settings. The likely impact of heightened comorbidity on attrition in usual care settings is more difficult to predict. There is some evidence that comorbid diagnoses and symptoms do not significantly predict or moderate outcomes for anxiety treatment in the context of RCTs (see Ollendick et al. [@CR45]). These results are promising, but generalization of these findings outside of RCT samples remains unclear. In truth, "pure" anxious youths are relatively rare, or rarely identified, in non-research usual care mental health settings and these children and adolescents could be characterized as clinically heterogeneous youths with clinically significant anxiety (Chavira et al. [@CR12]). Thus, separate examination of a community-based anxious population may be highly informative.

In addition to client characteristics, researchers have highlighted numerous differences between the interventions delivered in research clinics and community clinic care (e.g., Weisz et al. [@CR61], [@CR63], [@CR62]). For instance, therapy in RCTs tends to be more highly structured, problem-focused, and time-limited (Hunt and Andrews [@CR25]; Sledge et al. [@CR51]); by contrast, treatment in outpatient community centers tends to be unstructured and eclectic (Weersing and Weisz [@CR59]). Further, providers in RCTs typically receive extensive training and increased supervision compared to community-based providers. In addition, while usual care is open-ended, short-term research interventions may actually provide a larger dose of therapy. The mean length of treatment for empirically tested child anxiety psychosocial interventions is approximately 12 sessions (this mean was obtained by averaging the number of treatment sessions listed for each study included in a recent review by Silverman et al. ([@CR50]) of 32 clinical trials of treatment for youth anxiety and phobias), which is considerably higher than the mean number of three treatment sessions attended by youth in outpatient mental health settings (Hansen et al. [@CR23]; Harpaz-Rotem et al. [@CR24]; McKay and Bannon [@CR40]). Lack of manualized treatments in OMHCs adds a layer of complexity to definition of dropout, as there is no pre-set number of treatment sessions required in usual care. When attrition cannot be defined based on completion of a standard protocol, therapist judgment may provide the most valid and meaningful way to define dropout, as this approach considers the reason for and appropriateness of dropout given the course of care to date (Wierzbicki and Pekarik [@CR65]).

Despite differences in both client and setting characteristics, virtually nothing is known about whether these observed differences translate into predictors of treatment dropout among youths with anxiety in community settings. Accordingly, in the present study we aimed to extend previous investigations of treatment dropout by (a) examining attrition rates among youths with clinically significant levels of anxiety presenting at an OMHC; and (b) identify client characteristics associated with attrition in this sample. We reviewed the child treatment literature to guide our selection of a priori predictor variables for analysis in the current study. We included variables that (a) were associated with attrition in previous research (e.g., ethnic minority status, single parent household), (b) highlighted clinical characteristics relevant to our use of a community clinic sample (e.g., comorbid externalizing symptoms), and/or (c) were theoretically linked to internalizing youth, regardless of previous significance of findings in externalizing samples (e.g., age, gender, severity of anxiety, and comorbid depression symptoms). Based on our review, we selected age, gender, family composition (single- or two-parent household), minority status (yes/no; with follow-up subgroup analyses), and symptom severity of anxiety, depression, and externalizing behavior as a priori predictors of treatment dropout. We hypothesized that attrition would be higher in this community clinic sample than in previous studies utilizing RCT samples and that minority status, living with one parent, and increased depression severity would be adversely associated with dropout.

Method {#Sec1}
======

The current project was approved by institutional review boards (IRBs) at each affiliated institution.

Sample {#Sec2}
------

Participants were drawn from families seeking mental health services at an urban, community-based OMHC. All intake appointments were completed between July 2004 and March 2007, and all youths attended their last appointment prior to May 2008. During this timeframe, 1,316 youths were scheduled for intake and 990 intakes were completed. Youths were excluded from the current study if they were missing data on anxiety symptoms (*n* = 176), were in immediate crisis (e.g., actively suicidal) and completed an urgent intake assessment (*n* = 127), or if a caregiver was unable to complete standardized measures in English (*n* = 122). A total of 565 youths were screened for significant symptoms of anxiety. Youths were defined as clinically anxious if caregivers reported (a) clinically significant symptoms (total score ≥25) on the Screen for Child Anxiety and Related Emotional Disorders (SCARED; Birmaher et al. [@CR9]) and/or (b) a diagnosis of an anxiety disorder (generalized anxiety, separation anxiety, social anxiety, panic disorder, post-traumatic stress disorder) in the past month, with at least intermediate impairment rating in one or more areas, on the Diagnostic Interview Schedule for Children for DSM-IV (DISC-IV; Shaffer et al. [@CR49]). To be included in the study, subjects had to have both measures completed and meet these criteria on at least one measure.

One-hundred ninety-seven youths ages 5--18 (*M* = 10.28 years, SD = 3.34) met these entry criteria and were included in analyses. The sample was 69.3% male and ethnically diverse; 49.7% Caucasian, 24.4% African American, 15.7% Hispanic/Latino, and 10.1% other. The majority of youths (84.3%) lived with one or both of their biological parents. Sixty-seven percent of families in present sample were receiving Medicaid health coverage; the sample predominantly falls within the low- to middle-class range of socioeconomic status (SES). Parental education and occupation were not collected routinely by the clinic and were available for less than 60% of families, precluding our ability to use these variables as proxies for SES. Table [1](#Tab1){ref-type="table"} presents demographic characteristics for the total sample and by dropout status.Table 1Demographic characteristics of dropouts and non-dropouts by definition of attrition Total\
Sample (%)Clinician-rated dropoutDefinition 1: Yes/No (CR)Definition 2: phase of treatment (PT)Non-dropout (%)Any dropout (%)Pre-treatment (0--1 sessions)Early (2--6 sessions)Late (≥7 sessions)*N*197 (100)96 (48.7)101 (51.3)252848Demographic Gender (male)124 (62.9)64 (66.7)60 (59.4)171132 Mean age (SD)10.28 (3.33)10.13 (3.43)10.43 (3.26)10.729.5710.78 Caucasian98 (49.7)50 (52.1)48 (47.5)7^a^1328 Any minority99 (50.3)46 (47.9)^1^53 (52.5)18^1^1520  African-American48 (24.4)22 (22.9)26 (25.7)12^a,b,c^411  Hispanic/Latino31 (15.7)14 (14.6)17 (16.8)5^c^84  Other20 (10.1)10 (10.4)10 (9.9)1^d^35 Lives with both parents63 (32.0)32 (33.3)31 (30.7)71113 % Medicaid132 (67.0)61 (63.5)71 (71.3)171341No. sessions attended Median91460420.5 Range0--780--740--78   Note: Groups with same letter superscripts are significantly different at *p* \< 0.05; same number superscripts denotes *p* \< 0.10

Clinical characteristics of this sample are provided in Table [2](#Tab2){ref-type="table"}. Youths in this sample also were clinically diverse; 60.0% of cases met criteria for two or more disorders on the DISC-IV, with an average of 2.3 disorders (range = 0--6). Of the total sample, 67.0% endorsed scores above the clinical cutoff on the SCARED, and 36.5% of cases met diagnostic criteria for a current diagnosis of any anxiety disorder1[1](#Fn1){ref-type="fn"} on caregiver report on the DISC-IV (see Table [2](#Tab2){ref-type="table"}). Clinician diagnoses were not recorded in medical records for 45 youths, however, of the 152 youths with a documented clinician diagnosis, 77 received at least one anxiety-related diagnosis by the clinician.[2](#Fn2){ref-type="fn"} Notably, comorbidity with a non-anxiety disorder in this sample is high. This observation is consistent with existing reports that the majority of youths served in community-based clinics have externalizing problems and underscores the critical need to understand what clinically anxious youths in this setting "look like."Table 2Clinical characteristics of dropouts and non-dropouts by definition of attrition (past month)TotalClinician-rated dropoutSample (%)Definition 1: Yes/No (CR)Definition 2: phase of treatment (PT)Non-dropout (%)Any dropout (%)Pre-treatment (0--1 sessions)Early (2--6 sessions)Late (≥7 sessions)*N*197 (100)96 (48.7)101 (51.3)252848Mean Sx scores (SD) SCARED29.89 (13.94)29.33 (13.58)30.43(14.32)27.72 (12.01)30.29 (12.27)31.92 (16.41) SMFQ10.45 (6.49)9.50^a,b^ (5.86)11.37^a^ (6.94)10.08 (7.15)10.82 (5.82)12.35 (7.42)^b^ SNAP-ODD1.72 (0.89)1.68 (.89)1.76 (.89)1.57 (0.81)1.84 (0.94)1.81 (0.91)Above clinical cutoff SCARED132 (67.0)64 (66.768 (67.3)142232 SMFQ94 (47.7)40 (41.7)54 (53.5)111132 SNAP-ODD122 (61.9)60 (62.5)62 (61.4)131831DISC diagnoses Any anxiety disorder72 (36.5)36 (37.5)36 (36.6)101214 Generalized18 (9.1)8 (8.3)10 (9.9)--37 Separation40 (20.3)20 (20.8)20 (19.8)767 Social31 (15.7)14 (14.6)17 (16.8)386 PTSD1 (0.5)1 (1.0)-------- Any depressive disorder33 (16.8)13 (13.5)20 (19.8)5411 MDD15 (7.6)5 (5.2)10 (9.9)127 Dysthymia18 (9.1)8 (8.3)10 (9.9)424 Any externalizing disorder126 (63.9)57 (59.4)69 (68.3)151836 ADHD107 (54.3)53 (55.2)54 (53.5)131427 ODD120 (60.9)53 (55.2)67 (66.3)151735 CD51 (25.9)26 (27.1)25 (24.8)21013Note: Groups with same letter superscripts are significantly different at *p* \< 0.05*SCARED* screen for child anxiety and related disorders, *SMFQ* short mood and feelings questionnaire, *SNAP*-*ODD* Swanson, Nolan, and Pelham---oppositional defiant disorder subscale, *DISC* diagnostic interview schedule for children, *PTSD* post traumatic stress disorder, *MDD* major depressive disorder, *ADHD* attention deficit hyperactivity disorder, *ODD* oppositional defiant disorder, *CD* conduct disorder

Setting {#Sec3}
-------

The OMHC is located in New Haven, Connecticut and provides services to children and adolescents. Across all presenting problems, youths who present for treatment in this clinic are predominantly lower SES, and over half of youths have current or past involvement with child welfare services (e.g. foster care or juvenile justice system). Treatment tends to be eclectic and delivered by social workers (Walker et al. [@CR58]); in this anxious sample, psychotherapy was delivered by 58 social workers, social work trainees, and psychology or psychiatry fellows; 68% of cases were treated by social workers. For all youths in this sample, psychotherapy services were recommended at time of intake assessment, and no youths were referred or seen for medication management without therapy. At intake, all families participated in a systematic assessment procedure designed to comply with state reporting requirements and to characterize the patient population and services. Study consent was sought from the legal guardian of all youths as part of this procedure. In some cases, when a legal guardian was not available to consent, we obtained a waiver from the institution's IRB to access medical records.

Measures {#Sec4}
--------

Demographic data were collected from caregivers at the first intake visit. Clinical assessments were collected during intake, and results were provided to clinicians prior to treatment delivery. Dropout ratings were coded by clinicians at patient discharge.

The Screen for Child Anxiety and Related Emotional Disorders, parent report (SCARED-P; Birmaher et al. [@CR9]) is a 41-item parent-report questionnaire designed to screen for elevated anxiety symptoms in children and adolescents. The SCARED has demonstrated good validity and reliability in both clinical and non-clinical samples. There is evidence that a score of 25 on the SCARED has good sensitivity and specificity for distinguishing diagnosable anxious from non-anxious youths and predicting DSM-IV anxiety disorders (Birmaher et al. [@CR8]; Bailey et al. [@CR6]). This score also adequately discriminates between youth who are anxious and those who are depressed or have disruptive behavior disorders, but are not anxious (Birmaher et al. [@CR9]; Monga et al. [@CR43]). The SCARED-P was used to screen youths into the study and to assess anxiety symptom severity.

The Diagnostic Interview Schedule for Children (NIMH DISC-IV; Shaffer et al. [@CR49]) is a structured diagnostic assessment of youth psychopathology with good reliability and validity. The clinic uses a computer-based version of the diagnostic interview completed by the caregiver with the assistance of a trained interviewer. To reduce participant burden, only the modules listed in Table [2](#Tab2){ref-type="table"} were routinely administered to families, and low-prevalence disorders (e.g., Obsessive Compulsive Disorder) were assessed by clinicians when indicated. The DISC was used in the current study to determine the presence of and impairment associated with an anxiety disorder within the past month and to assess the overall diagnostic profile of each youth. In addition, the DISC provided information about whether youths lived with both parents.

The Short Mood and Feelings Questionnaire parent report (SMFQ-P; Angold et al. [@CR1]) is a 13-item parent-report questionnaire derived from the 34-item mood and feelings questionnaire designed to assess symptoms of depression in youth based on DSM-IV criteria. The SMFQ has correlated highly with other depression self-report measures and has reliably distinguished clinically depressed youth from non-depressed youth. A cutpoint of 11 or more identified the top 6% of scores in a general youth population (Angold et al. [@CR2]). The SMFQ was used to assess depression symptomatology.

The Swanson, Nolan, and Pelham (SNAP-IV; Swanson [@CR55]) is a 40-item scale measuring the presence and severity of externalizing behaviors with evidence of good reliability and validity. In the present study, the score on the ODD subscale was used to assess the extent to which externalizing behavior predicted treatment attrition.

Definition of Dropout {#Sec5}
---------------------

We adopted a two-part definition of treatment dropout. First, we used a dichotomous dropout variable (yes/no) based on clinician-rated reason for discharge. Next, youths classified as dropouts were further delineated by number of sessions in order to categorize youths who dropped out during different phases of treatment.

### Global Clinician-Rated Dropout (CR) {#Sec6}

Upon termination of services, clinicians indicated the reason for discharge in youths' medical record. Subsequently, two raters reviewed these data and classified subjects as dropouts (yes/no) based on the clinician-documented *reason* for discharge. Dropouts were defined as youths or families who unilaterally decided to terminate treatment and discontinued contact with clinic (e.g., child/family chose to discontinue, unable to follow up with family). Non-dropouts were defined as youths or families who, with their clinician, agreed that presenting problems were solved, symptoms were abated, or terminated for reasons beyond their control (e.g., moving locations, required outside referral). The raters demonstrated good inter-rater reliability (*k* = 0.89). This approach to classifying dropout status is in line with recommendations made by Wierzbicki and Pekarik ([@CR65]) and similar to what has been used in previous studies of attrition (e.g., Kendall and Sugarman [@CR33]; Garcia and Weisz [@CR20]; Kazdin and Mazurick [@CR29]; Kazdin and Wassell [@CR30]; Miller et al. [@CR42]).

### Phase of Treatment (PT) {#Sec7}

To examine attrition across the course of treatment, we used a revised definition from previous work to further classify youths by time to dropout (Kazdin and Mazurick [@CR29]). Time points were defined as follows: pre-treatment (0--1 sessions, where 0 indicates that the intake was completed but treatment was not initiated), early treatment (2--6 sessions), or late treatment (≥7 sessions). These time frames were selected for two main reasons. First, the mean length of treatment for empirically tested child anxiety psychosocial interventions is approximately 12 sessions, and 7 or more sessions maps on to completion of roughly half of a probably efficacious treatment dose of child anxiety psychosocial intervention. Second, the cutoff that distinguishes early from late dropout corresponds to those employed by Kazdin and Mazurick ([@CR29]) in a sample of externalizing youths, which may provide an interesting point of comparison.

Data Analysis {#Sec8}
-------------

We implemented a two-step approach to data analysis for each of our definitions of attrition (CR and PT). First, chi-square and *t*-tests were used to compare attrition rates and characteristics of dropouts and non-dropouts. Second, we employed multivariable binomial and multinomial logistic regression models to predict CR and PT dropout using our full a priori set of seven variables (age, gender, minority status, single parent status, and anxiety, depression, and externalizing symptom severity). We planned to retain significant predictors from the full models for follow-up tests in parsimonious post-hoc prediction models. Values for five cases with missing data (on no more than two items) on either the depression or externalizing continuous measures were imputed using the EM algorithm through the ICE function in STATA. Patterns of results were the same for dimensional measures of symptom severity (SCARED, SMFQ, SNAP), and DISC-IV diagnoses for anxiety, depression, and externalizing problems; therefore, dimensional clinical measures were used in all regression analyses to increase power. Due to the small extant youth anxiety attrition literature, we adopted an exploratory approach and a critical alpha was set at 0.05 for all comparisons.

Results {#Sec9}
=======

Attrition {#Sec10}
---------

Table [1](#Tab1){ref-type="table"} lists demographic characteristics and attrition rates for each definition. By the global CR definition, there were 101 (51.3%) treatment dropouts and 96 non-dropouts (48.7%). Dropouts attended a median of six sessions. The most commonly cited reason for discharge was "Child/family chose to discontinue." Non-dropouts attended a median of 14 sessions, and the most often cited reason for discharge was "Services to be provided by another agency." When dividing the 101 CR dropouts by time point of dropout, 25 cases discontinued services pre-treatment, 28 discontinued services in the early treatment phase, and 48 discontinued in the late treatment phase. Overall, treatment dropouts experienced higher levels of depression than non-dropouts, *t*~195~ = 2.03, *p* \< 0.05, as predicted a priori (see Table [2](#Tab2){ref-type="table"})*.* The early dropout group contained a marginally higher proportion of ethnic minority youth, *χ*^2^ (3, *N* = 197) = 6.48, *p* \< 0.10.

Prediction of Dropout {#Sec11}
---------------------

A multivariate logistic regression analysis was used to predict CR dropout status (yes/no) using all seven a priori predictors. Only depression symptoms reliably predicted dropout in the presence of all predictor variables (OR = 1.06, 95% CI: 1.00, 1.12, *p* \< 0.05). Subsequently, depression severity was included to test a final parsimonious model consisting solely of this significant predictor. This model was significant, *χ*^2^ (1, *N* = 197) = 4.11, *p* \< 0.05, and appeared to be a good fit using the Hosmer and Lemeshow Goodness-of-Fit test, *χ*^2^ (8) = 11.871, *p* \> 0.50, indicating that prediction of dropout improved when depression symptoms were taken into account. Specifically, in the absence of other variables, the odds of being classified as a dropout reliably increased by a factor of 1.05 (95% CI: 1.00, 1.09, *p* \< 0.05), or 5%, for each single-point increase in SMFQ score. In terms of clinical significance, for every increase of one standard deviation in depression symptoms (*SD* = 6.49), the risk of dropout is 1.34 times higher, such that the odds of dropout increased by 34% for a youth whose SMFQ score was one standard deviation above the mean compared to a youth who had the mean SMFQ score.

To predict PT dropout, multinomial logistic regression was performed through SPSS 16.0 NOMREG. In the presence of all seven a priori variables, minority status was significantly associated with increased odds of attrition in the pre-treatment phase (OR = 2.78, 95% CI: 1.03, 7.54) and higher depression symptom ratings increased the odds of dropout in the late treatment phase (OR = 1.08, 95% CI: 1.00, 1.16). Subsequently, minority status and depression severity were included to test a parsimonious model consisting of these two significant predictors. The parsimonious model was statistically significant, *χ*^2^ (6, *N* = 197) = 12.66, *p* \< 0.05, and appeared a good fit to these data using the Deviance test, *χ*^2^ (150) = 134.17, *p* \> 0.80, indicating that depression symptoms and minority status alone reliably distinguished non-dropouts from dropouts at different phases of treatment. The odds of dropping out pre-treatment was nearly three times higher for ethnic minorities (OR = 2.89, 95% CI: 1.10, 7.60), and late treatment dropouts were more likely to report higher levels of depression than non-dropouts (OR = 1.07, 95% CI: 1.01, 1.13). The odds of dropping out late in treatment increased by 7% for every one-point increase in SMFQ score. In other words, the odds of dropping out for youths in the late treatment phase with an SMFQ score one standard deviation above the mean were 1.54 times (54%) higher than youths with the mean SMFQ score.

Based on examination of mean rates of dropout by ethnic group (see Table [1](#Tab1){ref-type="table"}), we suspected that the association between minority status and pre-treatment dropout was due to higher attrition of African-American youth. To unpack this relationship, we compared African-American youth to youth from all other ethnic groups. We computed the reduced multinomial model replacing the original minority status variable (yes/no) with a new dummy-coded contrast (African-American/Other). In this model, pre-treatment dropouts were three times more likely to be African-American than any other ethnicity (OR = 3.03, 95% CI: 1.16, 7.92), indicating that ethnicity effects were driven by African-American youths in this sample. Increase in depression symptoms continued to predict late treatment dropout (OR = 1.08, 95% CI: 1.01, 1.16).

Discussion {#Sec12}
==========

Anxiety is distressing, impairing, chronic, and highly prevalent in youths. However, little is known about these youths in community practice settings and whether youths receive an adequate course of care. To address this gap, this study examined the rates and predictors of attrition among clinically complex youths with significant anxiety symptoms receiving mental health services in an urban community-based OMHC. Attrition in the sample (51%) was within the range reported in other outpatient samples (50--75%; Kazdin [@CR28]); however, this rate was substantially higher than the 23% rate previously reported for anxious youths in university anxiety clinics and RCTs (Kendall and Sugarman [@CR33]; Pina et al. [@CR47]). Parceling dropout by phase of treatment was useful in identifying predictors that did not emerge when examined by overall dropout (yes/no). In the present study, depression symptom severity and minority status increased risk for attrition, though the action of these predictors varied by definition of attrition. Youth age, gender, single parent status, severity of co-occurring externalizing symptoms, and severity of anxiety did not significantly increase risk for attrition in this sample.

Higher depression symptoms at intake predicted dropout overall, but particularly during the late treatment phase (≥7 sessions). This is informative given that anxiety and depression in youth, although highly co-occurring (Axelson and Birmaher [@CR5]; Lewinsohn et al. [@CR35]), are often studied separately. These results are consistent with those of previous studies indicating that depression is adversely associated with treatment dropout in children with conduct problems (Luk et al. [@CR36]) and within a general outpatient youth sample (Dierker et al. [@CR16]). Further exploration of mechanisms through which depression influences attrition is warranted. In this sample, depression severity was not significantly related to stressful contextual variables such as single parent status, involvement with child welfare protective services, or receipt of Medicaid.

Our ethnicity results were driven largely by African-American youths in the sample, who were three times more likely than youths of other ethnic groups to initiate termination after completing zero or one treatment sessions. This corroborates previous findings that ethnic minorities are at greater risk for attrition early in the treatment process (Kazdin and Mazurick [@CR29]; Weersing and Weisz [@CR59]). In this sample, African-American youths were *not* significantly more depressed than youths of other ethnic groups (*t*~195~ = 1.59, *p* = 0.12). In previous research that found a significant association between minority status and attrition, African-American youths comprised the largest minority group (Kendall and Sugarman [@CR33]). The second attrition study that did not produce ethnicity effects sampled largely Latino youths (Pina et al. [@CR47]), and it is plausible that sample differences in ethnic composition may have contributed to the contrasting findings of the impact of "minority status." In future work, consideration of specific ethnic groups may be more informative than examination of combined ethnic minority groups. In addition, it would be valuable to unpack cultural and economic variables that may underlie the effect of "ethnicity." For example, minority status is often confounded with socioeconomic disadvantage (Kazdin [@CR69]), and although Medicaid coverage did not predict dropout in any follow-up analyses, significantly more ethnic minorities received Medicaid insurance than Caucasian families in our sample, *χ*^2^ (1, *N* = 195) = 15.68, *p* \< 0.001. This investigation was not powered to unravel potential interactions with ethnicity and SES, although larger, diverse community samples typically found in OMHCs may provide a valuable arena for exploring these effects. Notably, in our sample, other stressful contextual factors (e.g., single parent status, child welfare involvement) did not separate African-American youth from youth of other ethnic minority groups, and these factors did not predict attrition.

Present findings extend previous examinations of attrition by studying a representative group of youths who present in community-based mental health settings. These findings are necessarily limited by several constraints of this "real world" setting. In this study, clinician-rated reason for discharge, rated from medical records, was used as the most valid indicator of the intentions of the child and the family for terminating services. However, clinician judgment of reason for discharge is subjective and likely to vary by clinician. Given that services are not time-limited in this OMHC, it is quite possible that some clinicians may tolerate a greater number of missed sessions and keep a case open longer than others. In addition, the phase of treatment definition in the current study may not correspond to the same phase of treatment within other OMHCs and RCTs (e.g., a youth at session 5 in an RCT may be in a very different place in treatment than a youth at session 5 in an OMHC).

The current sample of youths was selected from a broader clinic sample to have clinically significant levels of anxiety using well-validated standardized assessment tools and maps on to other definitions used to identity anxious youths in public service settings (Chavira et al. [@CR12]). Nevertheless, findings must be interpreted with some notable caveats. First, given that many of these youth met criteria for a number of disorders, it may be best to conceptualize these youth as comprising a clinically anxious/comorbid sample. This is consistent with previous reports that the diagnostic profiles of anxious youths in community-based service settings are complex and have high rates of non-anxiety comorbidity (Chavira et al. [@CR12]; Southam-Gerow et al. [@CR53]) and presents a distinct difference from youths typically seen in RCTs. Second, it would be useful to have information regarding the primacy of anxiety symptoms in this sample. If information regarding primary diagnoses were available, it would be interesting to examine associations between attrition and specific anxiety types. The relatively low prevalence of individual anxiety disorders and the high comorbidity within the anxiety disorders (see Table [2](#Tab2){ref-type="table"}) limited our ability to meaningfully examine attrition by anxiety type in this sample or to examine the influence of anxiety alone on attrition. However, such analyses may not be the most informative in this sample given the clinical complexity that characterizes anxious youths in public service settings.

Further, as our data collection was embedded in the daily operation of an active outpatient clinic, our ability to assess certain predictors of attrition was limited by the mission of this setting. This excluded several potentially meaningful predictors of attrition, such as parental diagnoses, which were not systematically assessed as a component of intake into child-based services. In addition, it was difficult to ascertain reliable information regarding medication use. As medication-only services are not provided in this clinic, many youths receive medication prescriptions from pediatricians and providers outside of this clinic prior to, during, and after therapy services. This information may not have been systematically reported to or documented by therapists and findings regarding medication status in this sample would likely be misleading at best. Furthermore, medication use is a complex issue that can vary considerably depending on how medication use is conceptualized (e.g., SSRI vs. non-SSRI vs. no medication; start of medication during treatment, and so on). While we were not in a position to examine the various patterns of medication use, these issues may influence treatment engagement and attendance and warrant future study. Future investigations also would benefit from interviews with providers and families to elucidate process-related reasons for dropout, including perceived barriers to treatment, client--therapist ethnic match, therapeutic alliance, and the pace and content of treatment (Garcia and Weisz [@CR20]; Gross et al. [@CR22]; McCabe [@CR39]; Stevens et al. [@CR54]).

Implications and Future Directions {#Sec13}
----------------------------------

There are important service setting characteristics that may have bearing upon interpretation and implications of results. For instance, the rates of non-anxiety psychiatric comorbidity were extremely high in this sample. This profile is consistent with that anxious youths served in public sectors of care, for whom comorbidity rates of approximately 60% with non-anxiety disorders have been reported (Chavira et al. [@CR12]). Our goal in this investigation was to identify a population who would serve as potential targets for dissemination of youth anxiety treatments as they exist in this outpatient setting. This level of comorbidity has important implications for the treatment planning and engagement process in this outpatient setting. While many of these youths present with a variety of other problems, anxiety is likely an important component of their clinical picture and targeted treatment of anxiety in these youths seems reasonable. In at least one investigation of youths in public settings, significant anxiety in the context of other psychiatric comorbidities was a risk factor for a number of adverse outcomes, including receipt of inpatient treatment (Chavira et al. [@CR12]). In order to better understand factors that may influence treatment and outcomes in this setting, examination of current treatment and course of treatment of youths with significant anxiety is critical.

In addition, mean duration of treatment length varies substantially between research and practice. Youths in OMHCs attend an average of three sessions (Hansen et al. [@CR23]; McKay and Bannon [@CR40]). By contrast, among youth anxiety psychotherapies that meet criteria for "probably efficacious treatment" (see Silverman et al. [@CR50]), the shortest intervention (Barrett et al. [@CR7]) was 12 sessions of CBT. Furthermore, a study examining outcomes after a full course of treatment (12 weeks) from a specialty outpatient clinic for anxiety found that only 43% of these youths receiving CBT had a "good" treatment response (Southam-Gerow et al. [@CR52]). Notably, less than half (44%) of the participants with significant anxiety in the current OMHC sample received 12 sessions or more. If the same 43% positive response rate were to hold in this sample, only about one in five youths would be expected to have a positive response even if current "best practice" interventions for anxiety were offered. While it is possible that retention may have improved if therapists were providing manualized CBT for anxiety, this remains an open question. A recent study examining the transportability of CBT for depression in a community mental health clinic did not observe significant differences in total missed sessions between youths who received CBT and those who received usual care (Weisz et al. [@CR64]). One recent study has demonstrated that child-focused CBT can be transported to community-based mental health clinics for some anxiety disorders (Farrell et al. [@CR18]); however, as the authors note, the sample was more similar to those seen in traditional RCTs than in typical community mental health practice. A number of recent studies have investigated child anxiety treatment in novel settings, including schools and primary care (e.g., Farrell et al. [@CR18]; Ginsburg et al. [@CR21]; Masia Warner et al. [@CR37]; Weersing et al. [@CR60]), however, several of these child anxiety investigations routinely exclude youths with depressive comorbidity. Indeed, of 32 studies included in a recent review of evidence-based treatments for child phobia and anxiety (Silverman et al. [@CR50]), at least six (19%) excluded youths with depression (three did not provide this information). Of the 23 studies in which depression was not an exclusion criterion, eight did not enroll any depressed youth, five did not provide rates of depression, and the remaining studies included a small proportion (average of 8.5% of sample) of concurrently depressed youth. Inclusion of youths with elevated levels of depression may help mollify concerns that findings from research clinics may not generalize to other service settings, especially given our provocative data that this common comorbidity may substantially increase the risk of treatment dropout.

Present findings also suggest the potential value of research aimed at improving response and increasing family engagement very early in treatment. Our results indicate that African-American youths are at risk for dropping out within the first few sessions, which merits additional, targeted efforts to engage these youths and their families at treatment initiation. It also is plausible that one reason for early attrition is lack of quick clinical improvement. For more clinically severe youths, converging data show that combination treatments (i.e., CBT and SSRI) may be efficacious in maximizing speed of response for both anxiety and depression (Walkup et al. [@CR70]). In addition, internalizing youths may benefit from integrated psychosocial treatments designed to target both anxiety and depression to produce a quick and robust response (Trosper et al. [@CR56]; Weersing et al. [@CR60]). Broadly, speed of response may be critical for provision of services in usual care settings given that many youths attend treatment for short periods and underscores the importance of attrition prevention early in treatment. Further examination of whether rapid improvement in internalizing symptoms increases retention, and factors that influence response rate (e.g., medication use), is warranted.

Broadly speaking, we see value in developing a more complete picture of patterns of service use among clinically and demographically diverse youths for whom anxiety and depression present significant difficulties. Specifically, identification of predictors of treatment attrition may lead to fruitful efforts to develop interventions and pre-treatment or in-session strategies that may mitigate the impact of these variables. Such techniques may help bridge the gap between research and practice by increasing the "robustness" of treatment and facilitating dissemination efforts.
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Anxiety not otherwise specified, specific phobia, and obsessive--compulsive disorder were not assessed in this setting, thus, it is likely that the value reported for any anxiety disorder is an underestimate of the prevalence of anxiety in this sample.

As a conservative test, we attempted to re-run all analyses within this subsample of youths who received a diagnosis of anxiety by clinician report (*n* = 77). Pattern of results was similar in the subsample as in our larger sample. For example, for clinician-rated dropout (Y/N), depression symptom severity increased the odds of attrition in the full model (OR = 1.11, 95% CI: 0.99--1.24), though this effect lapsed into non-significance (*p* = 0.07) likely due to the smaller sample size. Nevertheless, these findings lend confidence to the pattern of findings within a sample with significant anxiety. We were unable to example predictors of Phase of Treatment dropout within this subsample given insufficient number of cases in each cell.
